At a glance
ClinicalIndex Comparison RecordN/ACompleted· 73 enrolled
Drug / intervention
SPECT acquisitionsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of a Multipurpose CZT Camera in Gated Tomographic Radionuclide Angiography: a Head to Head Comparison With a Cardiac Dedicated CZT Device
In Brief
A clinical study evaluating SPECT acquisitions for Cardiac Function. Completed, enrolled 73 participants across 1 site.
Detailed Summary
Tomographic radionuclide angiography (or blood pool) is a reproducible method to evaluate left ventricular ejection fraction that is needed during oncological treatments or to evaluate cardiopathies. Cardiac-dedicated CZT systems allowed dose or time reduction. Multipurpose CZT cameras have not yet been evaluated in this indication. Moreover, the impact of attenuation correction is not known.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Function
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedNov 2020
Enrollment StartDec 2020
Primary CompletionAug 2021
TodayJul 2026
First PostedNov 16, 2020
Enrollment StartDec 30, 2020
Primary CompletionAug 6, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.6 years ago
Interventions
SPECT acquisitionsother
All patients will undergo SPECT acquisitions with both multipurpose CZT camera and cardiac dedicated CZT camera.